Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [896]
News [1734]
Articles [203]
Editorials [5]
Conferences [126]
elearning [18]
Comment: Advances in breast cancer presented at ASCO 2014
Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland
Comment: Advances in breast cancer presented at ASCO 2014 ( Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland )
1 Jun 2014
Comment: Advances in lung cancer presented at ASCO 2014
Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland
Comment: Advances in lung cancer presented at ASCO 2014 ( Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland )
1 Jun 2014
Medyczne nowości w raku gruczołu krokowego
Prof Piotr Jan Wysocki - Poznan University of Medical Sciences, Poznan, Poland
Medyczne nowości w raku gruczołu krokowego ( Prof Piotr Jan Wysocki - Poznan University of Medical Sciences, Poznan, Poland )
1 Jun 2014
Second-line treatment with ramucirumab plus docetaxel extends survival in...
Dr Maurice Pérol - Centre Léon Bérard, Lyon, France
Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC ( Dr Maurice Pérol - Centre Léon Bérard, Lyon, France )
31 May 2014
Ibrutinib significantly delays disease progression and extends survival in...
Dr John Byrd - The Ohio State University, Columbus, USA
Ibrutinib significantly delays disease progression and extends survival in resistant or relapsed CLL ( Dr John Byrd - The Ohio State University, Columbus, USA )
31 May 2014
Upcoming trends in myeloma therapy
Dr Kenneth Anderson; Prof Gareth Morgan; Prof Paul Richardson
Upcoming trends in myeloma therapy ( Dr Kenneth Anderson; Prof Gareth Morgan; Prof Paul Richardson )
15 May 2014
Recent advances in mantle cell lymphoma: Expert panel discussion
Prof Simon Rule; Prof Umberto Vitolo; Prof Pier Luigi Zinzani; Prof Emanuele...
Recent advances in mantle cell lymphoma: Expert panel discussion ( Prof Simon Rule; Prof Umberto Vitolo; Prof Pier Luigi Zinzani; Prof Emanuele Zucci )
13 May 2014
Lecture: Current use of systemic therapies in localised disease
Dr Rainy Umbas - University of Indonesia, Jakarta, Indonesia
Lecture: Current use of systemic therapies in localised disease ( Dr Rainy Umbas - University of Indonesia, Jakarta, Indonesia )
12 May 2014
Debate: Will chemotherapy continue to be standard treatment for symptomatic...
Dr Paul de Souza - University of Western Sydney, New South Wales, Australia
Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (for) ( Dr Paul de Souza - University of Western Sydney, New South Wales, Australia )
12 May 2014
Debate: Will chemotherapy continue to be standard treatment for symptomatic...
Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany
Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (against) ( Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany )
12 May 2014
Rituximab versus idelalisib in refractory CLL
Prof John Gribben - Queen Mary University London, London, UK; Prof Peter...
Rituximab versus idelalisib in refractory CLL ( Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen - St James’ University Hospital, Leeds, UK )
9 May 2014
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic...
Dr Valentin Goede - University of Cologne, Cologne, Germany
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients ( Dr Valentin Goede - University of Cologne, Cologne, Germany )
8 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation